Skip to main content

Supreme Court won't hear bid to challenge thalidomide settlement

The statue representing justice looks out from the Supreme Court of Canada over the Parliamentary precinct in Ottawa, Thursday March 25, 2021. THE CANADIAN PRESS/Adrian Wyld The statue representing justice looks out from the Supreme Court of Canada over the Parliamentary precinct in Ottawa, Thursday March 25, 2021. THE CANADIAN PRESS/Adrian Wyld
Share
OTTAWA -

The Supreme Court of Canada will not hear a bid to challenge approval of a settlement agreement for Canadians born with birth defects because of the drug thalidomide.

The Federal Court approved the agreement -- the government's third effort over the years to provide compensation -- finding it to be fair and reasonable.

Five class members who were dissatisfied with the court's approval unsuccessfully asked the Federal Court of Appeal for permission to appeal.

The Supreme Court did not provide reasons for refusing to examine the matter.

Thalidomide was approved in Canada to treat morning sickness in pregnant women for less than a year in the early 1960s but it was available unofficially for several years both before and after that.

The drug caused major problems in fetuses, particularly shortened and malformed limbs.

CTVNews.ca Top Stories

Local Spotlight

N.B. man wins $64 million from Lotto 6/49

A New Brunswicker will go to bed Thursday night much richer than he was Wednesday after collecting on a winning lottery ticket he let sit on his bedroom dresser for nearly a year.

Record-setting pop tab collection for Ontario boy

It started small with a little pop tab collection to simply raise some money for charity and help someone — but it didn’t take long for word to get out that 10-year-old Jace Weber from Mildmay, Ont. was quickly building up a large supply of aluminum pop tabs.